It's a finite resource challenge to claim Moore's Law, a paper about silicon chips, somehow "provided a fundamental benchmark" for genome sequencing costs.
That's a retrospective fit, not a cause; you can chart anything against anything if you try hard enough.
The real breakthroughs in genome sequencing came from massive investments in lab equipment, chemical processes, and specialized staff, not from an article about computing.
We're talking about tangible effort and dwindling budgets for specialized R&D, not a philosophical alignment.